Highlights Haisco Pharmaceutical Group Co., Ltd.

Stocks

002653

CNE100001BC7

Pharmaceuticals

End-of-day quote Shenzhen S.E. Other stock markets 2026-07-17			5-day change	1st Jan Change
71.27 ^CNY	-10.00%		+2.80%	+38.87%

Jul. 14	Haisco Pharmaceutical Gets China IND Application Acceptance for Novel Inflammatory Drug	MT
Jul. 14	Haisco Pharmaceutical's China IND Application for Novel Inflammatory Drug Accepted	MT

Highlights

Jul. 14	Haisco Pharmaceutical Gets China IND Application Acceptance for Novel Inflammatory Drug	MT
Jul. 14	Haisco Pharmaceutical's China IND Application for Novel Inflammatory Drug Accepted	MT
Jul. 09	Haisco Pharma's H1 Profit to Skyrocket to Up to 575%; Shares Up 3%	MT
Jun. 12	Haisco Pharma Gets Nod to Trial HSK46256 Tablets; Shares Up 3%	MT
Jun. 01	Haisco Pharmaceutical Group Receives U.S. FDA Marketing Approval For Cipepofol Injection	CI
Jun. 01	Haisco Pharmaceutical Group Co., Ltd. and Eli Lilly and Company Announce Licensing and Research Collaboration Agreement to Develop Innovative Medicines Across Multiple Therapeutic Areas	CI
May. 27	Haisco Pharma Gets Nod to Trial HSK44459 Cream	MT
May. 11	Haisco Pharmaceutical Gets China Regulatory Nod to Market Postoperative Pain Drug	MT
Apr. 27	Haisco Pharmaceutical Q1 Profit Up 1,090%, Revenue Jumps 75%	MT
Apr. 26	Haisco Pharmaceutical Group Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2026	CI
Apr. 26	Haisco pharmaceutical q1 net profit up 1,089.9% y/y	RE
Apr. 13	Haisco Pharmaceutical Group Co., Ltd. Enters Exclusive License Agreement with AbbVie	CI
Apr. 13	Haisco Pharmaceutical Expects Q1 Profit to Skyrocket to 1,095%; Shares Up 3%	MT
Apr. 13	Haisco Pharmaceutical's 2025 Profit Falls 34%, Revenue Rises 18%; Shares Up 3%	MT
Apr. 12	Haisco Pharmaceutical Group Co., Ltd. announces Annual dividend, payable on May 15, 2026	CI
Apr. 12	Haisco Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2025	CI
Apr. 12	Haisco pharmaceutical sees Q1 net profit up 923.3-1095.0% Y/Y	RE
Apr. 09	Haisco Pharmaceutical's Pediatric Drug Included in China's Starlight Program; Shares Fall 7%	MT
Apr. 08	Chinese Drug Regulator Puts Haisco Pharmaceutical's HSK39004 Inhaler in Breakthrough Drug List; Shares Down 4%	MT
Mar. 17	Haisco Pharmaceutical's Unit Gets Nod to Trial Prostate Cancer Drug; Shares Up 5%	MT
Mar. 15	Haisco Pharmaceutical's Subsidiary Gets Nod for Clinical Trial of HSK55879 Tablets; Shares Up 5%	MT
Mar. 12	Chinese Drug Regulator Accepts Haisco Pharmaceutical's Clinical Trial Application for Dermatitis Cream	MT
Mar. 12	Haisco Pharmaceutical's HSK31679 Tablet Added to China's Breakthrough Therapy Program	MT
Mar. 08	Haisco Pharmaceutical Gets Marketing Approval For Rare Blood Disorder Drug	MT
Mar. 05	Haisco Pharmaceutical's Subsidiary Gets Nod to Trial Respiratory Disease Drug; Shares Up 4%	MT